Pfizer-allied molecular glue startup Triana collects $120M Series Bnews2025-12-03T15:28:30+00:00December 3rd, 2025|Endpoints News|
Excelsior Sciences raises $95M for small molecule drug discovery, manufacturingnews2025-12-03T13:00:11+00:00December 3rd, 2025|Endpoints News|
ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisitionnews2025-12-02T16:34:33+00:00December 2nd, 2025|Endpoints News|
Helicore stops work on clinical GIP antagonist after Phase 1 resultsnews2025-12-02T13:46:05+00:00December 2nd, 2025|Endpoints News|
Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDAnews2025-12-02T11:30:10+00:00December 2nd, 2025|Endpoints News|
Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqelnews2025-12-01T11:00:24+00:00December 1st, 2025|Endpoints News|
Cormorant eyes another $400M healthcare fundnews2025-11-26T13:02:16+00:00November 26th, 2025|Endpoints News|
Kallyope scraps one of two mid-stage migraine drugsnews2025-11-26T10:37:29+00:00November 26th, 2025|Endpoints News|
Craig Crews, Mikael Dolsten raise $32M for Quarry Theranews2025-11-24T12:00:59+00:00November 24th, 2025|Endpoints News|
Flagship and portfolio companies do deals with GSK, Merck KGaA and Saudi Arabianews2025-11-20T14:27:08+00:00November 20th, 2025|Endpoints News|
